Additionally, some of the NSCLC cells with intact KRas or p53 yet are not protected by CDDO-Me, indicating that multiple oncogenic changes are required to confer resistance to CDDO-Me radioprotection. This evidence concerns the gene TP53 and non-small cell lung carcinoma.